CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...

The global prime editing and CRISPR market size was US$ 3,194.2 million in 2021. The global prime editing and CRISPR market is forecast to grow to US$ 17,618.4 million by 2030 by registering a ...

Imagine if you could fix a spelling mistake in a long document with just one click. Now, imagine doing the same with the genetic code of a plant or even a human cell. That’s ...

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

While artificial intelligence still dominated the industry, there were a couple of breakthroughs that defined the year ...

A single-dose CRISPR-CasRx nanotherapy targeting a host enzyme reduces SARS-CoV-2 viral load and promotes alveolar repair in a hamster model of long COVID, offering a promising strategy for treating ...

As the global population ages, 2025 has delivered a remarkable wave of new research aimed at supporting healthier brains in ...

Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in ...